Department of Biomedical Sciences, Cornell University, Ithaca, NY, USA.
Hypertension. 2013 Feb;61(2):382-7. doi: 10.1161/HYPERTENSIONAHA.111.00546. Epub 2012 Dec 17.
Reactive oxygen species and the NADPH oxidases contribute to hypertension via mechanisms that remain undefined. Reactive oxygen species produced in the central nervous system have been proposed to promote sympathetic outflow, inflammation, and hypertension, but the contribution of the NADPH oxidases to these processes in chronic hypertension is uncertain. We therefore sought to identify how NADPH oxidases in the subfornical organ (SFO) of the brain regulate blood pressure and vascular inflammation during sustained hypertension. We produced mice with loxP sites flanking the coding region of the NADPH oxidase docking subunit p22(phox). SFO-targeted injections of an adenovirus encoding cre-recombinase markedly diminished p22(phox), Nox2, and Nox4 mRNA in the SFO, as compared with a control adenovirus encoding red-fluorescent protein injection. Increased superoxide production in the SFO by chronic angiotensin II infusion (490 ng/kg min(-1) × 2 weeks) was blunted in adenovirus encoding cre-recombinase-treated mice, as detected by dihydroethidium fluorescence. Deletion of p22(phox) in the SFO eliminated the hypertensive response observed at 2 weeks of angiotensin II infusion compared with control adenovirus encoding red-fluorescent protein-treated mice (mean arterial pressures=97 ± 15 versus 154 ± 6 mm Hg, respectively; P=0.0001). Angiotensin II infusion also promoted marked vascular inflammation, as characterized by accumulation of activated T-cells and other leukocytes, and this was prevented by deletion of the SFO p22(phox). These experiments definitively identify the NADPH oxidases in the SFO as a critical determinant of the blood pressure and vascular inflammatory responses to chronic angiotensin II, and further support a role of reactive oxygen species in central nervous system signaling in hypertension.
活性氧和 NADPH 氧化酶通过尚未明确的机制导致高血压。中枢神经系统产生的活性氧被认为可促进交感神经输出、炎症和高血压,但 NADPH 氧化酶在慢性高血压中对这些过程的贡献尚不确定。因此,我们试图确定大脑中的穹窿下器官 (SFO) 中的 NADPH 氧化酶如何在持续高血压期间调节血压和血管炎症。我们构建了loxP 位点侧翼 NADPH 氧化酶衔接亚基 p22(phox)编码区的小鼠。与编码红色荧光蛋白的对照腺病毒相比,SFO 靶向注射编码 cre 重组酶的腺病毒显著降低了 SFO 中的 p22(phox)、Nox2 和 Nox4 mRNA。慢性血管紧张素 II 输注(490 ng/kg min(-1) × 2 周)增加 SFO 中超氧化物的产生,这在 SFO 中 cre 重组酶处理的小鼠中被二氢乙啶荧光检测到减弱。与对照腺病毒编码红色荧光蛋白处理的小鼠相比,SFO 中 p22(phox)的缺失消除了血管紧张素 II 输注 2 周时观察到的高血压反应(平均动脉压分别为 97 ± 15 与 154 ± 6 mm Hg;P=0.0001)。血管紧张素 II 输注还促进了明显的血管炎症,表现为激活的 T 细胞和其他白细胞的积累,而 SFO p22(phox)的缺失则阻止了这种炎症。这些实验明确确定 SFO 中的 NADPH 氧化酶是对慢性血管紧张素 II 血压和血管炎症反应的关键决定因素,并进一步支持活性氧在高血压中的中枢神经系统信号中的作用。